Question-Order Effect Experiment to Measure HIV Stigma
2 other identifiers
interventional
180
1 country
1
Brief Summary
Question-order effect experiment to measure HIV-related stigma among people living with HIV (PWH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Nov 2023
Shorter than P25 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 6, 2025
CompletedFirst Submitted
Initial submission to the registry
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 14, 2025
CompletedMay 14, 2025
May 1, 2025
1.2 years
May 5, 2025
May 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Self-esteem
...do you think less of yourself because of your HIV status? (single item)
Baseline (assessed at the time the survey is administered)
Self-respect
...have you felt ashamed because of your HIV status? (single item)
Baseline (assessed at the time the survey is administered)
Experiences of harassment due to HV status
* have you lost respect or standing in the community because of your HIV status? * have people talked badly about you because of your HIV status? * have you been verbally insulted, harassed and/or threatened because of your HIV status? * have you been physically assaulted because of your HIV status? * has someone else disclosed your HIV status without your permission? * have you felt that people have not wanted to sit next to you, for example on public transport, at church or in the waiting room, because of your HIV status? (six items)
Baseline (assessed at the time the survey is administered)
Study Arms (2)
V1
EXPERIMENTALAs this is a survey experiment, the "intervention" involves random assignment to a survey questionnaire with specific treatments. The first treatment is a questionnaire with questions about internalized stigma followed by questions of experienced stigma. Each question is answered as Yes/No/It depends on knowing more details.
V2
EXPERIMENTALAs this is a survey experiment, the "intervention" involves random assignment to a survey questionnaire with specific treatments. The second treatment is a questionnaire with questions about experienced stigma followed by questions about internalized stigma. Each question is answered as Yes/No/It depends on knowing more details.
Interventions
Each version of the questionnaire includes a different order of statements about which study participants are asked to provide a Yes, No, or It depends response.
Each version of the questionnaire includes a different order of statements about which study participants are asked to provide a Yes, No, or It depends response.
Eligibility Criteria
You may qualify if:
- \- All HIV-positive (self-reported) adults who consider Nyakabare their primary place of residence and who are capable of providing consent
You may not qualify if:
- Minors younger than 18 years of age, with the exception of emancipated minors
- Persons who do not consider Nyakabare Parish their primary place of residence, e.g. persons who happen to be visiting Nyakabare at the time of the survey or who own a home in Nyakabare but spend most of their time outside of the parish
- Persons with psychosis, neurological damage, acute intoxication, or other cognitive impairment (all of which are determined informally in the field by non-clinical research staff in consultation with a supervisor)
- Persons who are not HIV positive
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mbarara University of Science and Technology
Mbarara, Uganda
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander C Tsai, MD, PhD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Psychiatry
Study Record Dates
First Submitted
May 5, 2025
First Posted
May 14, 2025
Study Start
November 2, 2023
Primary Completion
January 6, 2025
Study Completion
January 6, 2025
Last Updated
May 14, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share